Inventor · disambiguated record
Natalie Winblade Nairn
Also filed as: NAIRN NATALIE · NAIRN NATALIE W · NAIRN NATALIE WINBLADE
11 granted patents·15 pending applications·105 citations·filing 2007–2024
89Inventor score
Files withBLAZE BIOSCIENCE INC13ALLOZYNE INC4FRED HUTCHINSON CANCER CENTER4HUTCHINSON FRED CANCER RES2GRABSTEIN KENNETH1
Top patents by PatentIndex Score
26 records- 0194US8568706B2Modified human interferon-beta polypeptidesGRABSTEIN KENNETH H·Filed 2009·Granted Oct 29, 2013·33 cites·12 claims
- 0293US7829659B2Methods of modifying polypeptides comprising non-natural amino acidsALLOZYNE INC·Filed 2008·Granted Nov 9, 2010·27 cites·17 claims
- 0390US11559580B1Tissue-homing peptide conjugates and methods of use thereofBLAZE BIOSCIENCE INC·Filed 2021·Granted Jan 24, 2023·4 cites·20 claims
- 0489US7632492B2Modified human interferon-β polypeptidesALLOZYNE INC·Filed 2007·Granted Dec 15, 2009·27 cites·7 claims
- 0588US11090358B2Cartilage-homing peptidesHUTCHINSON FRED CANCER RES·Filed 2016·Granted Aug 17, 2021·4 cites·27 claims
- 0687US11866466B2Tumor homing and cell penetrating peptide-immuno-oncology agent complexes and methods of use thereofBLAZE BIOSCIENCE INC·Filed 2018·Granted Jan 9, 2024·3 cites·22 claims
- 0787US11013814B2Cartilage-homing peptide conjugates and methods of use thereofBLAZE BIOSCIENCE INC·Filed 2018·Granted May 25, 2021·3 cites·25 claims
- 0883US11331393B2Renal-homing peptide conjugates and methods of use thereofBLAZE BIOSCIENCE INC·Filed 2018·Granted May 17, 2022·3 cites·30 claims
- 0978US2025115648A1Chlorotoxin conjugates and methods of use thereofBLAZE BIOSCIENCE INC·Filed 2024·Application pending·0 cites
- 1074US2024309058A1Tumor homing and cell penetrating peptide-immuno-oncology agent complexes and methods of use thereofBLAZE BIOSCIENCE INC·Filed 2023·Application pending·0 cites
- 1172US2023364183A1Cartilage-homing peptidesFRED HUTCHINSON CANCER CENTER·Filed 2023·Application pending·0 cites
- 1271US12048750B2Tissue-homing peptide conjugates and methods of use thereofBLAZE BIOSCIENCE INC·Filed 2022·Granted Jul 30, 2024·0 cites·18 claims
- 1371US11648290B2Cartilage-homing peptidesFRED HUTCHINSON CANCER CENTER·Filed 2021·Granted May 16, 2023·0 cites·20 claims
- 1465US2020188536A1Chlorotoxin conjugates and methods of use thereofBLAZE BIOSCIENCE INC·Filed 2019·Application pending·0 cites
- 1565US2008096819A1Amino acid substituted moleculesALLOZYNE INC·Filed 2007·Application pending·0 cites
- 1665US2021260205A1Cartilage-homing peptide conjugates and methods of use thereofBLAZE BIOSCIENCE INC·Filed 2021·Application pending·0 cites
- 1763US10202447B2Antibody derivativesMEDIMMUNE LTD·Filed 2015·Granted Feb 12, 2019·1 cites·6 claims
- 1857US2008214439A1Amino acid substituted moleculesALLOZYNE INC·Filed 2008·Application pending·0 cites
- 1955US2025326866A1Transferrin receptor targeting peptide oligonucleotide complexes and methods of use thereofBLAZE BIOSCIENCE INC·Filed 2022·Application pending·0 cites
- 2055US2025195673A1Compositions and methods for selective depletion of target moleculesFRED HUTCHINSON CANCER CENTER·Filed 2021·Application pending·0 cites
- 2153US2024287147A1Pd-l1 binding peptides and peptide complexes and methods of use thereofFRED HUTCHINSON CANCER CENTER·Filed 2021·Application pending·0 cites
- 2248US2021171589A1Truncated cartilage-homing peptides and peptide complexes and methods of use thereofBLAZE BIOSCIENCE INC·Filed 2019·Application pending·0 cites
- 2344US2020262877A1Ion channel-binding peptides and methods of use thereofBLAZE BIOSCIENCE INC·Filed 2018·Application pending·0 cites
- 2442US2016096869A1Chlorotoxin conjugates and methods of use thereofBLAZE BIOSCIENCE INC·Filed 2015·Application pending·0 cites
- 2538US2014127209A1Antibody derivativesGRABSTEIN KENNETH·Filed 2013·Application pending·0 cites
- 2636US2019375786A1Stable peptides and methods of use thereofHUTCHINSON FRED CANCER RES·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Natalie Winblade Nairn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →